|
Volumn 949, Issue , 2001, Pages 292-294
|
SERMs, ethnicity, and clinical trials: Opportunities and challenges
|
Author keywords
Clinical trials; Ethnicity; SERMs
|
Indexed keywords
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST CANCER;
CANCER PREVENTION;
CANCER RISK;
CAUCASIAN;
CONFERENCE PAPER;
DRUG METABOLISM;
ENDOMETRIUM CANCER;
ETHNIC DIFFERENCE;
FEMALE;
HUMAN;
LIFESTYLE;
NEGRO;
POPULATION RESEARCH;
PRACTICE GUIDELINE;
RISK BENEFIT ANALYSIS;
STATISTICAL ANALYSIS;
STROKE;
VEIN THROMBOSIS;
|
EID: 0035683804
PISSN: 00778923
EISSN: None
Source Type: Book Series
DOI: 10.1111/j.1749-6632.2001.tb04035.x Document Type: Conference Paper |
Times cited : (5)
|
References (15)
|